{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:50:25Z","timestamp":1768398625655,"version":"3.49.0"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T00:00:00Z","timestamp":1321920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> Corneal neovascularization (CNV) is thought to negatively influence visual acuity. New therapeutic options that offer a differentiated influence on the ingrowths or regression of either corneal blood or lymphatic vessels force us to re\u2010evaluate the association between CNV and visual acuity.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A systematic review was conducted. Electronic databases were searched up to August 2009. Given the heterogeneity in study populations, interventions and measures of association, we were unable to undertake meta\u2010analysis. The association between CNV and visual acuity was reported descriptively for each study.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Eleven studies using either vascular endothelial growth factor inhibitor treatments (i.e. bevacizumab, Avastin<jats:sup>\u00ae<\/jats:sup>; Hoffmann\u2013La Roche AG, Basel, Switzerland) or an antiangiogenic treatment based on IRS\u20101 modulation [Gene\u2010Signal (GS) 101, Aganirsen<jats:sup>\u00ae<\/jats:sup>; GeneSignal, Evry (Paris), France] in a total of 131 patients (142 eyes) with corneal neovascularization were included. Ten of the eleven studies reported evidence of a statistically significant reduction in neovascularization following treatment. However, only four studies reported a statistically significant improvement in visual acuity following therapy. We found no studies that assessed the patient\u2010level association between the change in neovascularization and visual acuity.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> This systematic review found that there is currently weak evidence to support the hypothesis that in patients with pathological neovascularization, a treatment\u2010related reduction in neovascularization is associated with an increase in visual acuity. There is a need for future appropriately designed studies.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2011.02312.x","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T12:36:17Z","timestamp":1321965377000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The association between corneal neovascularization and visual acuity: a systematic review"],"prefix":"10.1111","volume":"91","author":[{"given":"Bjoern","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,22]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.01.039"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318159019f"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701799101"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0570"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-007-0684-4"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2008.08.007"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004170100313"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000183485.85636.ff"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.016"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.18"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31817786ad"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01571.x"},{"key":"e_1_2_6_14_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011","author":"Higgins JPT","year":"2011"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.42"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.02.013"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-009-1099-1"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/08820530902802013"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070172"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.11.003"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1993.1177"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31817c41e3"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-009-1934-0"},{"key":"e_1_2_6_24_1","first-page":"624","article-title":"Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells","volume":"51","author":"Sholley MM","year":"1984","journal-title":"Lab Invest"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318158f6ad"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-200201000-00010"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01399.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01585.x"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2011.02312.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2011.02312.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T06:07:39Z","timestamp":1698646059000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2011.02312.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/j.1755-3768.2011.02312.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2011.02312.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,22]]},"assertion":[{"value":"2011-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}